


Healthcare News Roundup: Generic
HSMN NewsFeed - 14 Mar 2007
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
HSMN NewsFeed - 6 Mar 2007
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
HSMN NewsFeed - 6 Mar 2007
Perrigo Company to Acquire Generic Dermatological Products From Glades Pharmaceuticals
Perrigo Company to Acquire Generic Dermatological Products From Glades Pharmaceuticals
HSMN NewsFeed - 5 Mar 2007
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
HSMN NewsFeed - 23 Feb 2007
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
HSMN NewsFeed - 6 Feb 2007
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
HSMN NewsFeed - 6 Feb 2007
Generic Medical Devices Receives CE Mark for the GMD Universal Circumcision Clamp
Generic Medical Devices Receives CE Mark for the GMD Universal Circumcision Clamp
HSMN NewsFeed - 2 Feb 2007
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
HSMN NewsFeed - 1 Feb 2007
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
HSMN NewsFeed - 31 Jan 2007
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
HSMN NewsFeed - 31 Jan 2007
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
HSMN NewsFeed - 31 Jan 2007
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
HSMN NewsFeed - 30 Jan 2007
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
HSMN NewsFeed - 23 Jan 2007
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
HSMN NewsFeed - 22 Jan 2007
Generic Medical Devices Receives 510(k) Clearance for the GMD Universal Circumcision Clamp
Generic Medical Devices Receives 510(k) Clearance for the GMD Universal Circumcision Clamp
HSMN NewsFeed - 19 Jan 2007
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
